Home NDC 73150-150 BRIUMVI
Product NDC 73150-150
11-digit product format 731500150
Labeler code 73150
Product ID 73150-150_4b34fc66-ea84-161b-e063-6294a90ac575
Type HUMAN PRESCRIPTION DRUG
Nonproprietary name ublituximab
Dosage form INJECTION, SOLUTION, CONCENTRATE
Route INTRAVENOUS
Labeler TG Therapeutics, Inc.
Application BLA761238
Marketing category BLA
Marketing start 2022-12-28
Substance UBLITUXIMAB
Active strength 150 mg/6mL
Pharmacologic classes CD20-directed Antibody Interactions [MoA], CD20-directed Cytolytic Antibody [EPC]
NDC exclude flag No
Listing certified through 2027-12-31
Current FDA listing Yes Reported adverse events (FAERS/openFDA)# Adverse event summaries are temporarily unavailable. Other product information remains available.
Additional Listing Data#
Finished product Yes
Brand name base BRIUMVI
Listing expiration 2027-12-31 Active Ingredients# Ingredient, Strength table Ingredient Strength UBLITUXIMAB 150 mg/6mL
Harmonized UNII identifiers# UNII identifiers page 1 of 1 · 1 matching rows.
Identifier, FDA.report destination table Identifier FDA.report destination U59UGK3IPC Internal UNII lookup
Harmonized RxCUI identifiers# RxCUI identifiers page 1 of 1 · 2 matching rows.
Identifier, FDA.report destination table Identifier FDA.report destination 2626353 Internal RxNorm lookup 2626359 Internal RxNorm lookup
Harmonized SPL set identifiers# SPL set identifiers page 1 of 1 · 1 matching rows.
DailyMed Product Concepts# DailyMed Package Descriptions# Package NDC, Product, Description table Package NDC Product Description Form Quantity Strength SPL version 73150-150-06 BRIUMVI 6 mL in 1 VIAL, SINGLE-DOSE INJECTION, SOLUTION, CONCENTRATE 6 21 73150-150-06 BRIUMVI 1 in 1 CARTON INJECTION, SOLUTION, CONCENTRATE 1 21
DailyMed Dashboard NDC Coverage# NDC, Dashboard title, SPL version table NDC Dashboard title SPL version Validation Dashboard ZIP 73150-150 BRIUMVI (UBLITUXIMAB) INJECTION, SOLUTION, CONCENTRATE [TG THERAPEUTICS, INC.] 16 Current NDC, Legacy NDC, 2 package rows 20250213_3a77cd8c-811b-407c-9140-d0c5c26435c2.zip
openFDA label cross-check# OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Matched openFDA labels page 1 of 1 · 1 matching rows.
Purple Book Biologic Products# BLA, Proprietary name, Proper name table BLA Proprietary name Proper name License type Status Latest source 761238 Briumvi ublituximab-xiiy 351(a) Rx 2026-09-01
DailyMed RxNorm Mappings# Packages# Package NDC, 11-digit format, Description table Package NDC 11-digit format Description Marketing start Marketing end Sample Exclude flag Status 73150-150-06 73150015006 1 VIAL, SINGLE-DOSE in 1 CARTON (73150-150-06) / 6 mL in 1 VIAL, SINGLE-DOSE 2022-12-28 0000-00-00 No No Current